flâneur

Liquidity in Drug Discovery – Bharath Ramsundar – Decentralized Protocol and Deep Drug Discovery Researcher

rbharath.github.io · 1,094 words · saved by 1 readers

One of the most fundamental problems in drug discovery is that potential drugs don’t have market value until they’ve passed human trials. Unfortunately for prospective drug hunters, running human trials of proposed medicine costs tremendous amounts of money. As a result, only a few players are capable of creating salable assets in drug discovery. The market is essentially discrete; large amounts of money are divided up among perhaps a dozen new approved drugs per year. This situation chokes innovation, since available capital has to be funneled into relatively conservative bets.

Liquidity in Drug Discovery One of the most fundamental problems in drug discovery is that potential drugs don’t have market value until they’ve passed human trials. Unfortunately for prospective drug hunters, running human trials of proposed medicine costs tremendous amounts of money. As a result, only a few players are capable of creating salable assets in drug discovery. The market is essentially discrete; large amounts of money are divided up among perhaps a dozen new approved drugs per year. This situation chokes innovation, since available capital has to be funneled into relatively conse

saved by

related reading